Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2013-004376-35Phase 2Completed
Phase 2, randomised, single-blind trial in coronary arteriosclerosis comparing Ticagrelor arm with Clopidogrel arm (2 arms). Primary endpoint: Change in carotid-femoral pulse wave velocity at 3 hours. Started Nov 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2013-004376-35.